Beta Blockers In Acute Ischemic Stroke "BIAS"


Phase 2/3 Results N/A

Summary of Purpose

The objective of this trial is to assess the safety and efficacy of neuro- and cardioprotective effects of propranolol in acute ischemic stroke. Furthermore, exploratory analyses of cardiologic-electrophysiologic and immunologic parameters will be performed.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 12 October 2015.

1 Jan 2010 1 Feb 2010 1 Oct 2011 1 Apr 2013 1 Oct 2015 Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Design

  • Allocation: Randomized
  • Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor)
  • Purpose: Prevention
  • Endpoint: Safety/Efficacy Study
  • Intervention: Parallel Assignment